1867 - Characteristics and Outcomes of Patients with SARS-CoV-2 Reinfections Requiring Treatment in a COVID-19 Ambulatory Treatment Program

Saturday, October 22, 2022

12:15 PM – 1:30 PM US ET

Location: Hall B + C

Co-Author(s)

Austin Golia, PharmD (he/him/his)

PGY-2 Infectious Diseases Pharmacy Resident
Montefiore Medical Center
Queens, New York, United States

Yi Guo, PharmD, BCIDP

Clinical Pharmacy Manager of Infectious Diseases/Co-director of Animicrobial Stewardship Progam
Montefiore Medical Center
Bronx, New York, United States
TM

Terrence D. McSweeney, PharmD

Infectious Disease Pharmacist
Montefiore Medical Center
Massapequa, New York, United States
Mei H. Chang, PharmD, BCPS, BCCCP, BCIDP (she/her/hers)

Clinical Pharmacy Manager - Infectious Diseases
Montefiore Medical Center
Bronx, NY, United States
HB

Hongkai Bao, PharmD, BCIDP

Infectious Diseases Pharmacist
Montefiore Medical Center
Bronx, New York, United States
Priya Nori, MD, FSHEA, FIDSA

Priya Nori, MD
Montefiore Medical Center
Bronx, NY, United States